24/7 Wall St. has put together a preview of Johnson & Johnson, Procter & Gamble and the other Dow Jones industrial average companies scheduled to report their quarterly results this week.
Friday was a solid for the broad U.S. markets, bouncing back from the devastating drop on Wednesday and Thursday. Each of the major averages gained over 1% in the session with the Nasdaq posting…
Tetraphase Pharmaceuticals shares were up handily on Friday after the company announced the U.S. commercial launch of Xerava (eravacycline) for the treatment of complicated intra-abdominal infections.
Corium shares jumped on Friday after the company announced that it entered into a definitive merger agreement under which Gurnet Point Capital will acquire Corium.
Citigroup shares rose after it released a mixed third-quarter earnings report before the markets opened on Friday.
Wells Fargo reported mixed third-quarter financial results early Friday but shares were up a bit in premarket trading.
Thursday was a bad day for the broad U.S. markets. The Dow and the S&P 500 each dropped over 1.5% in the session, while the Nasdaq got away down less than 1%. Crude oil…
Compugen shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb will make a $12 million equity investment as part of its collaboration on a cancer trial.
Wells Fargo is set to release its third-quarter financial results before the markets open on Friday, and analysts are looking for strong year-over-year earnings growth.
CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration with Vertex Pharmaceuticals.
Livent shares disappointed investors when they entered the market on Thursday. The stock entered the market below the expected price range has only dropped lower as the day has gone on.
Square shares pulled back on Thursday after the company announced that there would be big changes at the top. Specifically, the chief financial officer is stepping down from this role.
JPMorgan is scheduled to release its latest quarterly results before the markets open on Friday, and analysts are looking for growth on the top and bottom lines.
Citigroup is scheduled to reveal its third-quarter results early on Friday and analysts are looking for solid growth on the top and bottom lines.
Delta Air Lines released better-than-expected quarterly results before the markets opened on Thursday.
Wednesday was a very bad day for the broad U.S. markets. The broad markets each dropped over 3% in the session, making this one of the worst trading days of the year. Crude oil…
Connected planning pioneer Anaplan expects to price 15 million shares for an initial public offering valued up to about $303 million.
IDT shares soared after it released its fiscal fourth-quarter financial results and announced share buybacks.
Ionis Pharmaceuticals shares were relatively flat on Wednesday after the company announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases.
AcelRx shares made a solid gain on Wednesday despite a less-than-favorable update from the FDA. However, there is a vote for approval on Friday. and that seems to be what investors are optimistic about.
